isradipine has been researched along with Eaton-Lambert Myasthenic Syndrome in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
el Far, O | 1 |
Marquèze, B | 1 |
Leveque, C | 1 |
Martin-Moutôt, N | 2 |
Lang, B | 1 |
Newsom-Davis, J | 1 |
Yoshida, A | 1 |
Takahashi, M | 1 |
Seagar, MJ | 1 |
Arsac, C | 1 |
Raymond, C | 1 |
Dargent, B | 1 |
Couraud, F | 1 |
Pouget, J | 1 |
Seagar, M | 1 |
2 other studies available for isradipine and Eaton-Lambert Myasthenic Syndrome
Article | Year |
---|---|
Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome.
Topics: Animals; Autoantibodies; Autoantigens; Brain; Calcium Channels; Calcium Channels, L-Type; Immunoglob | 1995 |
Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Topics: Amyotrophic Lateral Sclerosis; Animals; Autoantibodies; Brain; Calcium Channel Blockers; Calcium Cha | 1996 |